IN2013MU01918A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01918A
IN2013MU01918A IN1918MU2013A IN2013MU01918A IN 2013MU01918 A IN2013MU01918 A IN 2013MU01918A IN 1918MU2013 A IN1918MU2013 A IN 1918MU2013A IN 2013MU01918 A IN2013MU01918 A IN 2013MU01918A
Authority
IN
India
Prior art keywords
pyrazolylpyrimidinones
relates
compounds
conditions
cancers
Prior art date
Application number
Inventor
Kunju Vasu Kamala
Anil Nivsarkar Manish
Rameshchandra Sagar Sneha
Harikrishnabhai Pandya Dhaivatkumar
Prasad Dash Ranjeet
Original Assignee
Kamala Kunju Vasu Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamala Kunju Vasu Dr filed Critical Kamala Kunju Vasu Dr
Priority to IN1918MU2013 priority Critical patent/IN2013MU01918A/en
Publication of IN2013MU01918A publication Critical patent/IN2013MU01918A/en

Links

Abstract

The invention relates to novel pyrazolylpyrimidinones compounds which are used in management of diabetes, inflammatory conditions, immunoinflammatory conditions, autoimmune diseases, and cancers. The invention also relates to methods for the synthesis of pyrazolylpyrimidinones compounds according to present invention.
IN1918MU2013 2013-05-31 2013-05-31 IN2013MU01918A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1918MU2013 IN2013MU01918A (en) 2013-05-31 2013-05-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1918MU2013 IN2013MU01918A (en) 2013-05-31 2013-05-31

Publications (1)

Publication Number Publication Date
IN2013MU01918A true IN2013MU01918A (en) 2015-07-03

Family

ID=54394958

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1918MU2013 IN2013MU01918A (en) 2013-05-31 2013-05-31

Country Status (1)

Country Link
IN (1) IN2013MU01918A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11944626B2 (en) * 2016-06-20 2024-04-02 The Regents Of The University Of Michigan Small molecule inhibitors of ALDH and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11944626B2 (en) * 2016-06-20 2024-04-02 The Regents Of The University Of Michigan Small molecule inhibitors of ALDH and uses thereof

Similar Documents

Publication Publication Date Title
PH12015502565A1 (en) Anti-transferrin receptor antibodies and methods of use
PH12016501763A1 (en) Multispecific antibodies
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
PH12015502141A1 (en) Substituted xanthines and methods of use thereof
SG10201811017QA (en) Novel antibody frameworks
MX2015009888A (en) Aluminium casting alloy.
IN2014DN05885A (en)
EA201591712A1 (en) ANTIBIOTIC COMPOSITIONS BASED ON CEFTOLOSAN
MX2014005510A (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
AU2014237898A8 (en) Pan-ELR+ CXC chemokine antibodies
PH12016500598A1 (en) Protoxin-ii variants and methods of use
IN2013DE00266A (en)
EA201590503A1 (en) ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria
MA35877B1 (en) Phenylimidazopyrazoles substituted and their use
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
MX363385B (en) Treatment of sickle cell disease and inflammatory conditions.
MX2015016603A (en) Corticosteroid compositions.
IN2013MU01113A (en)
MX2016002027A (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof.
MX2015014470A (en) Combretastatin analogs.
IN2013MU01918A (en)
MX2015012902A (en) Synthesis of ent-progesterone and intermediates thereof.
MX369389B (en) Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions.
IN2013MU03768A (en)
IN2013CH05865A (en)